aa 861 has been researched along with 5,8,11,14-eicosatetraynoic acid in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (33.33) | 18.7374 |
| 1990's | 3 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (16.67) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Brodsky, JL; Chiang, A; Chung, WJ; Denny, RA; Goeckeler-Fried, JL; Havasi, V; Hong, JS; Keeton, AB; Mazur, M; Piazza, GA; Plyler, ZE; Rasmussen, L; Rowe, SM; Sorscher, EJ; Weissman, AM; White, EL | 1 |
| Henson, PM; Leslie, CC; Lew, DB; Riches, DW | 1 |
| Niwa, Y; Ohashi, T; Ozaki, Y | 1 |
| Kato, K; Murota, S | 1 |
| Fujimoto, R; Hata, F; Kubo, T; Nagao, T; Nishio, H; Takeuchi, T | 1 |
| Hata, F; Nishio, H; Takeuchi, T; Yagasaki, O | 1 |
6 other study(ies) available for aa 861 and 5,8,11,14-eicosatetraynoic acid
| Article | Year |
|---|---|
Increasing the Endoplasmic Reticulum Pool of the F508del Allele of the Cystic Fibrosis Transmembrane Conductance Regulator Leads to Greater Folding Correction by Small Molecule Therapeutics.
Topics: Alleles; Benzoates; Cells, Cultured; Cystic Fibrosis; Cystic Fibrosis Transmembrane Conductance Regulator; Endoplasmic Reticulum; Furans; Gene Deletion; HEK293 Cells; HeLa Cells; High-Throughput Screening Assays; Humans; Hydroxamic Acids; Microscopy, Fluorescence; Protein Folding; Protein Structure, Tertiary; Pyrazoles; RNA, Messenger; Small Molecule Libraries; Ubiquitination; Vorinostat | 2016 |
Role of endogenously derived leukotrienes in the regulation of lysosomal enzyme expression in macrophages exposed to beta 1,3-glucan.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Benzoquinones; beta-Glucans; beta-N-Acetylhexosaminidases; Cyclooxygenase Inhibitors; Dinoprostone; Glucans; Indomethacin; Leukotrienes; Lipoxygenase Inhibitors; Lysosomes; Macrophages; Male; Mice; Mice, Inbred BALB C; Phospholipases A; Phospholipases A2; SRS-A | 1991 |
A comparative study on the effects of inhibitors of the lipoxygenase pathway on neutrophil function. Inhibitory effects on neutrophil function may not be attributed to inhibition of the lipoxygenase pathway.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Benzoquinones; Calcimycin; Chemotaxis, Leukocyte; Epoprostenol; Humans; Hydroxides; Hydroxyl Radical; Leukotriene B4; Lipoxygenase Inhibitors; Masoprocol; N-Formylmethionine Leucyl-Phenylalanine; NADH, NADPH Oxidoreductases; NADPH Oxidases; Neutrophils; Phospholipases A; Phospholipases A2; Platelet Activating Factor; Quinones; Tetradecanoylphorbol Acetate; Umbelliferones | 1986 |
Lipoxygenase specific inhibitors inhibit murine lymphocyte reactivity to Con A by reducing IL-2 production and its action.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Animals; Benzoquinones; Caffeic Acids; Cells, Cultured; Cinnamates; Concanavalin A; Female; Indomethacin; Interleukin-2; Lipoxygenase Inhibitors; Lymphocyte Activation; Lymphocytes; Mice; Mice, Inbred BALB C; Quinones | 1985 |
Ca(2+)-independent fusion of secretory granules with phospholipase A2-treated plasma membranes in vitro.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Albumins; Amylases; Animals; Arachidonic Acid; Benzoquinones; Calcium; Cell Membrane; Cytoplasmic Granules; Egtazic Acid; Exocytosis; Fatty Acids; Indomethacin; Lipoxygenase Inhibitors; Lysophosphatidylcholines; Male; Membrane Fusion; Microscopy, Electron; Parotid Gland; Phospholipases A; Phospholipases A2; Quinacrine; Rats; Rats, Wistar | 1995 |
Ca(2+)-independent fusion of synaptic vesicles with phospholipase A2-treated presynaptic membranes in vitro.
Topics: 5,8,11,14-Eicosatetraynoic Acid; Acetylcholine; Albumins; Animals; Arachidonic Acid; Benzoquinones; Brain; Calcium; Egtazic Acid; Exocytosis; In Vitro Techniques; Indomethacin; Male; Membrane Fusion; Neurotransmitter Agents; Phospholipases A; Phospholipases A2; Quinacrine; Rats; Rats, Wistar; Swine; Synaptic Membranes; Synaptic Vesicles | 1996 |